This HTML5 document contains 203 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n10http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n13https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42458534
rdf:type
wikibase:Item
schema:description
2009年論文 مقالة علمية نشرت في 14 أغسطس 2009 2009년 논문 tieteellinen artikkeli scientific article published on 14 August 2009 artikulong pang-agham bilimsel makale мақолаи илмӣ wetenschappelijk artikel artykuł naukowy scientific article published on 14 August 2009 2009年论文 artículu científicu espublizáu en 2009 наукова стаття, опублікована в серпні 2009 บทความทางวิทยาศาสตร์ artigo científico bài báo khoa học научна статия naučni članak 2009年论文 videnskabelig artikel 2009年論文 artigo científico article científic teaduslik artikkel 2009年论文 2009年论文 vetenskaplig artikel научни чланак tudományos cikk artikull shkencor 2009年論文 article scientifique scientific article published on 14 August 2009 2009年论文 articolo scientifico vědecký článek სამეცნიერო სტატია artigo científico 2009年の論文 articol științific wissenschaftlicher Artikel vedecký článok научни чланак vitskapeleg artikkel 2009年论文 ১৪ আগস্ট ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ article scientific מאמר מדעי artículo científico publicado en 2009 2009年論文 scienca artikolo επιστημονικό άρθρο 2009 nî lūn-bûn artikel ilmiah научная статья vitenskapelig artikkel 2009年論文
p:P577
wds:Q42458534-E6C6ED83-E2BA-4016-AC84-DD00A22EF437
wdt:P577
2009-08-14T00:00:00Z
p:P2888
wds:Q42458534-90F46F48-8A26-4889-85C0-3DF83F085070
wdt:P2888
n13:s00432-009-0654-9
p:P2860
wds:Q42458534-FEC2BB29-851E-4FF1-8717-ECA1D6A7A1FD wds:Q42458534-FCD0B1B0-B2DB-4F25-848A-FEAE0547FB6A wds:Q42458534-ACD8DDDE-EDF4-482A-BDA9-0CA06F6BBED5 wds:Q42458534-ADDBF816-771A-44E9-8913-0F6661421AC7 wds:Q42458534-B3A9A59C-EE63-44D5-BB60-5003E254FC87 wds:Q42458534-B4FFA7BD-76C1-43D7-951A-E6AF616824CE wds:Q42458534-9CEB77F9-34DC-4897-BF0B-4EE971ADAE6D wds:Q42458534-AA98ADBE-D4FD-4DA1-97DD-D99462BC6EB4 wds:Q42458534-9215D1A3-C2DD-4AFF-92CA-A4CE9F135E4B wds:Q42458534-96AAE36A-EE77-4C8E-9896-E7A4CDD636C0 wds:Q42458534-98F15E2C-8C6C-421E-A585-36AE4DB4FBE8 wds:Q42458534-78028084-3E02-49CE-A4ED-FFA51269BE53 wds:Q42458534-8E427FCA-73F1-41DA-91CA-6B959D2A5137 wds:Q42458534-91AE993B-8E17-471C-A410-42CACBA8B62A wds:Q42458534-E40F708E-D824-4C12-8F7B-FCFD2F6B0B85 wds:Q42458534-F007C812-8683-4BDD-9534-288975A65352 wds:Q42458534-F0832974-9E50-4E9E-95F8-AC5224B7F0FD wds:Q42458534-CAD968FD-134E-4570-B0E6-A0F60B956C65 wds:Q42458534-DCF1EDCB-1A48-4722-A0DB-CB4650FB49AF wds:Q42458534-E242E9DB-4E6F-43F1-8B23-4BDB538F8D19 wds:Q42458534-BFDEA850-2473-40CD-A4FE-5BE5BD00FE03 wds:Q42458534-C135E169-B186-42C4-A6E0-7AF4217293EA wds:Q42458534-C7C221A9-7E91-49DA-BDCE-270AEC8B455E wds:Q42458534-C81801AD-C59E-44BB-A508-7FE62DD785AE wds:Q42458534-BEF14C0D-D6A8-4F88-9212-663916B41FA9 wds:Q42458534-BFC203FF-C1C5-482B-A6DA-1062723BDF2D wds:Q42458534-13DED7BC-37C6-46B7-8F2C-06716D183999 wds:Q42458534-18F52164-94F2-4CCA-8B5E-922674FE4922 wds:Q42458534-224A0F90-C89E-4DC3-B590-B1BD3E3AE5BB wds:Q42458534-274B0BA5-9A09-4B43-9F21-A9DDB615DE31 wds:Q42458534-0D17313B-32B7-4168-B3CE-25C2D19E0975 wds:Q42458534-1045ED47-E2B0-4507-8AE8-66091AFBA0C6 wds:Q42458534-114B603A-6AFF-4732-A30C-BEBD2221132A wds:Q42458534-0A14CD71-B008-4402-853B-F84BA68254F1 wds:Q42458534-0A711B8D-193C-49D6-A0B1-4743E9A9ED92 wds:Q42458534-06B3C9E8-602A-4C54-9698-C7F050DFD7FC wds:Q42458534-6A1227E0-369D-4997-BE4F-1C155ADCD2AC wds:Q42458534-72FFE2FE-8CB9-45A4-9D9A-14E75B1CD8C1 wds:Q42458534-74FE029A-3F17-405C-A9E7-71C2C2ACF80D wds:Q42458534-5A12E150-5D91-4C2D-85BE-A23B3915E68D wds:Q42458534-619F20D6-B507-4429-A275-22660AB857C3 wds:Q42458534-62C37458-BA0E-46A3-8503-89C1C976F37D wds:Q42458534-43FA0486-FAC7-4B80-A1D5-2EB6F8DB14DA wds:Q42458534-51A7B8C2-558F-45E5-BD68-659FCE8FEE4F wds:Q42458534-53CBB570-B9B9-4BDF-B3D0-23E5593BC479 wds:Q42458534-2C342EA0-6E5B-4412-AE21-08E7F7C98483 wds:Q42458534-30B6F94F-336A-4F4F-B83B-9DF280CDB8BF wds:Q42458534-32DDECCC-4A93-40AD-98DC-C9155A66629F
wdt:P2860
wd:Q28131820 wd:Q35164084 wd:Q27860709 wd:Q36623843 wd:Q70110623 wd:Q36890177 wd:Q68547083 wd:Q74082953 wd:Q36100243 wd:Q44433157 wd:Q46771645 wd:Q42482998 wd:Q33348234 wd:Q42466578 wd:Q46911786 wd:Q35872734 wd:Q83137320 wd:Q46684308 wd:Q28306437 wd:Q44062327 wd:Q74611825 wd:Q42511189 wd:Q38302227 wd:Q44618276 wd:Q33304691 wd:Q28271274 wd:Q77438388 wd:Q46757502 wd:Q74715865 wd:Q43918762 wd:Q42517830 wd:Q81353372 wd:Q39605778 wd:Q44279198 wd:Q80559348 wd:Q38446760 wd:Q36338003 wd:Q45287928 wd:Q40147211 wd:Q40372047 wd:Q73494751 wd:Q27860904 wd:Q36678684 wd:Q35638695 wd:Q40675977 wd:Q77846215 wd:Q44861990 wd:Q46765380
rdfs:label
Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy
skos:prefLabel
Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy
schema:name
Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy
p:P50
wds:Q42458534-607A14B9-3199-48F5-B068-D24DABADDC8F wds:Q42458534-01A19493-1AD7-488D-BF7C-0FEE90BF1825 wds:Q42458534-041C2DCC-60EB-4E7C-9FD4-6E08E99E843B wds:Q42458534-08F9D5B6-3D3A-46B5-8883-425DAF630166 wds:Q42458534-0B898285-4392-4711-9B73-A5F77D7EC225 wds:Q42458534-F6695E14-D1E2-4FE2-816B-222C05049F9A wds:Q42458534-BA0B335C-8C6A-4997-B751-93D3BD822F75 wds:Q42458534-CB623041-93F4-45AF-94FE-D188849D2D16 wds:Q42458534-9D8CA0F0-9D5A-4A58-9615-131D7913304E wds:Q42458534-A2F47122-EA13-42E8-B8F2-7B2246D68D2F
wdt:P50
wd:Q114815707 wd:Q117240644 wd:Q117240629 wd:Q117240624 wd:Q114816064 wd:Q117240623 wd:Q114816021 wd:Q89430533 wd:Q93362007 wd:Q88925476
p:P1476
wds:Q42458534-4B875400-4315-4E05-A32B-0E1E139648BC
wdt:P1476
Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy
p:P304
wds:Q42458534-FEB5A571-744B-4ED9-BD6C-CEA6FE428ED8
wdt:P304
233-241
p:P31
wds:Q42458534-3BE9AA80-79AA-4608-B530-81230EEADBB5
wdt:P31
wd:Q13442814
p:P698
wds:Q42458534-6F7F6EA6-2B69-4221-AA07-AC280BA19B32
wdtn:P698
n12:19685074
wdt:P698
19685074
p:P1433
wds:Q42458534-BC079B47-4A69-4E89-9DE5-D16B1FB17F3D
wdt:P1433
wd:Q2081599
p:P433
wds:Q42458534-118C1C83-10C6-4BFE-98C4-42AF4BCADBAA
p:P478
wds:Q42458534-FB277A37-37E8-4B11-A69B-335F8A82DA42
wdt:P433
2
wdt:P478
136
p:P356
wds:Q42458534-998681A5-67A0-424C-BC61-82C602E96534
wdtn:P356
n10:S00432-009-0654-9
wdt:P356
10.1007/S00432-009-0654-9